4//SEC Filing
Hambleton Julie 4
Accession 0001104659-24-068674
CIK 0001773427other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:08 PM ET
Size
10.8 KB
Accession
0001104659-24-068674
Insider Transaction Report
Form 4
Hambleton Julie
Director
Transactions
- Sale
Common Stock
2024-06-03$39.41/sh−2,946$116,111→ 5,797 total - Sale
Common Stock
2024-06-03$41.49/sh−931$38,629→ 4,115 total - Sale
Common Stock
2024-06-03$40.57/sh−751$30,465→ 5,046 total - Sale
Common Stock
2024-06-03$42.09/sh−20$842→ 4,095 total
Footnotes (5)
- [F1]The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on March 1, 2024.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.02 to $40.01. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.02 to $40.96. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.02 to $42.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F5]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.06 to $42.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Documents
Issuer
SpringWorks Therapeutics, Inc.
CIK 0001773427
Entity typeother
Related Parties
1- filerCIK 0001578771
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:08 PM ET
- Size
- 10.8 KB